Ofloxacin
Back to searchMolecule Structure
Scientific Name
Ofloxacin
Description of the Drug
Ofloxacin is an antibacterial agent used for the treatment of bacterial infections in many parts of the body, including the respiratory tract, kidney, skin, soft tissue, and urinary tract.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01165
http://www.drugbank.ca/drugs/DB01165
Brand Name(s)
Exocin, Floxin, Floxin otic, Ocuflox, Ofloxacin, Tarivid, Tarivid 400, Tarivid i.v., Visiren
Company Owner(s)
Bausch And Lomb Pharmaceuticals Inc, Mankind Pharma Ltd, Amneal Eu Ltd, Akorn Operating Co Llc, Bedford Laboratories Div Ben Venue Laboratories Inc, Teva Pharmaceuticals Usa Inc, Alvogen Inc, Bausch And Lomb Inc, Fdc Ltd, Sandoz Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial DNA gyrase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2311224 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL24373 | |||
| PharmGKB | PA450684 | |||
| Human Metabolome Database | HMDB0015296 | |||
| DrugBank | DB01165 | |||
| PubChem: Thomson Pharma | 14876840 | |||
| PubChem | 3288597 | 4583 | ||
| Mcule | MCULE-5746531107 | |||
| NMRShiftDB | 60058706 | |||
| LINCS | LSM-4370 | |||
| Nikkaji | J242.858J | |||
| BindingDB | 50045004 | |||
| EPA CompTox Dashboard | DTXSID3041085 | |||
| DrugCentral | 1981 | |||
| Brenda | 33876 | 229741 | 36458 | 229740 |
| ChemicalBook | CB7103599 | |||
| Guide to Pharmacology | 10918 | |||
| rxnorm | FLOXIN | OFLOXACIN | OCUFLOX | |
| PubChem: Drugs of the Future | 12013736 | |||
| KEGG Ligand | C07321 | |||
| ChEBI | 194135 |
